Art. 3 Regulation (EU) 2022/139

Rules on the contracts with manufacturers required for the management of the Union antigen, vaccine and diagnostic reagent banks

In forcesince 16 Nov 2021cited 1×
1.

The Commission shall conclude contracts with selected manufacturers in order to manage, for category A diseases as referred to in Article 3 of Commission Implementing Regulation (EU) 2022/140, the following banks:

(a)

Union antigen banks;

(b)

Union vaccine banks;

(c)

Union diagnostic reagent banks.

2.

The Commission shall implement a public procurement procedure, in accordance with the rules laid down in Regulation (EU, Euratom) 2018/1046, for the selection of the manufacturers for the contracts referred to in paragraph 1.

3.

The contracts referred to in paragraph 1 shall cover at least the following matters:

(a)

conditions for the supply of various quantities and types of antigens, vaccines or diagnostic reagents to the Union antigen, vaccine and diagnostic reagent banks;

(b)

conditions for the secure storage and replacement of antigens, vaccines or diagnostic reagents;

(c)

in the case of Union antigen banks, guarantees and conditions for:

(i)

the rapid formulation of the antigens into vaccines;

(ii)

the production, bottling and labelling of vaccines reconstituted from the antigens;

(d)

conditions for the release, shipment and delivery of vaccines or diagnostic reagents;

(e)

conditions for the destruction and safe disposal of the antigens, vaccines or diagnostic reagents, or for the buy-back of antigens, for which the validity period has expired.

  • Regulation (EU) 2022/140Law

    … Impfstoffs erfolgt gemäß der Zulassung von Al(OH)3/Saponin- und/oder DOE-Impfstoffadjuvanzien, angepasst an den in Artikel 3 Absatz 1 bzw. Artikel 4 Absatz 1 der Delegierten Verordnung (EU) 2022/139 genannten Vertrag. 6. Die Kartons, die …